Nivolumab in combination with radiotherapy for unresectable advanced or recurrent gastric cancer (CIRCUIT trial): A 5-year update of the progression-free survival and local control outcomes. - Suzuki Y; Yoshida D; Mimura K; Ogata T; Yoshimoto Y; Katoh H; Hanayama H; Machida N; Sato H; Saze Z; Yamada T; Inokuchi Y; et al. (Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2026)